Robert Goldsby, MD


  1. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang L. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2023. PMID: 37549914


  2. Geiger EJ, Liu W, Srivastava DK, Bernthal NM, Weil BR, Yasui Y, Ness KK, Krull KR, Goldsby RE, Oeffinger KC, Robison LL, Dieffenbach BV, Weldon CB, Gebhardt MC, Howell R, Murphy AJ, Leisenring WM, Armstrong GT, Chow EJ, Wustrack RL. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. 2022. PMID: 35583517


  3. Stroud SG, Geiger EJ, Lichtensztajn DY, Goldsby RE, Cheng I, Wustrack R, Theologis AA. Survival of Patients With Primary Osseous Malignancies of the Mobile Spine Is Associated With Access to "Standard Treatment" Protocols. 2022. PMID: 35507547


  4. Pyke-Grimm KA, Franck LS, Halpern-Felsher B, Goldsby RE, Rehm RS. Day-to-Day Decision Making by Adolescents and Young Adults with Cancer. 2022. PMID: 35538622


  5. Sarah Stroud, Erik J. Geiger, Daphne Lichtensztajn, Robert Goldsby, Iona Cheng, Rosie Wustrack, Alexander A. Theologis. P76. An analysis of prognostic factors for patients with primary osseous malignancies of the mobile spine in the California Cancer Registry, 1988-2016. The Spine Journal 2021. PMID:


  6. Dieffenbach BV, Liu Q, Murphy AJ, Stein DR, Wu N, Madenci AL, Leisenring WM, Kadan-Lottick NS, Christison-Lagay ER, Goldsby RE, Howell RM, Smith SA, Oeffinger KC, Yasui Y, Armstrong GT, Weldon CB, Chow EJ, Weil BR. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. European journal of cancer (Oxford, England : 1990) 2021. PMID: 34391054



  7. Pyke-Grimm KA, Franck LS, Halpern-Felsher B, Goldsby RE, Rehm RS. 3 Dimensions of Treatment Decision Making in Adolescents and Young Adults With Cancer. Cancer nursing 2020. PMID: 33084293


  8. Lavergne V, Sabnis A, Tupule A, Davidson PR, Kline C, Matthay K, Nicolaides T, Goldsby R, Braunstein S, Fogh SE, Sneed PK, Menzel P, Nakamura A, DuBois SG, Haas-Kogan DA, Nakamura JL. Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy. Journal of pediatric hematology/oncology 2020. PMID: 31815884




  9. Penumarthy NL, Goldsby RE, Shiboski SC, Wustrack R, Murphy P, Winestone LE. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas. Cancer medicine 2019. PMID: 31838786


  10. Dirksen U, Brennan B, Le Deley MC, Cozic N, van den Berg H, Bhadri V, Brichard B, Claude L, Craft A, Amler S, Gaspar N, Gelderblom H, Goldsby R, Gorlick R, Grier HE, Guinbretiere JM, Hauser P, Hjorth L, Janeway K, Juergens H, Judson I, Krailo M, Kruseova J, Kuehne T, Ladenstein R, Lervat C, Lessnick SL, Lewis I, Linassier C, Marec-Berard P, Marina N, Morland B, Pacquement H, Paulussen M, Randall RL, Ranft A, Le Teuff G, Wheatley K, Whelan J, Womer R, Oberlin O, Hawkins DS, Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019. PMID: 31553693



  11. Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. European journal of cancer (Oxford, England : 1990) 2019. PMID: 30685685


  12. Pyke-Grimm KA, Franck LS, Patterson Kelly K, Halpern-Felsher B, Goldsby RE, Kleiman A, Rehm RS. Treatment Decision-Making Involvement in Adolescents and Young Adults With Cancer. Oncology nursing forum 2019. PMID: 30547960


  13. Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group. Pediatric blood & cancer 2018. PMID: 30378256


  14. Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA. Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2018. PMID: 29295883


  15. Goldsby RE, Stratton KL, Raber S, Ablin A, Strong LC, Oeffinger K, Sklar CA, Armstrong GT, Robison LL, Bhatia S, Leisenring WM. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. Cancer 2017. PMID: 29105081


  16. Eric Chang, Robert Goldsby, Sabine Mueller, Anu Banerjee. Late Effects of Treatment and Palliative Care. Pediatric CNS Tumors 2017. PMID:



  17. Sherborne AL, Lavergne V, Yu K, Lee L, Davidson PR, Mazor T, Smirnoff IV, Horvai AE, Loh M, DuBois SG, Goldsby RE, Neglia JP, Hammond S, Robison LL, Wustrack R, Costello JF, Nakamura AO, Shannon KM, Bhatia S, Nakamura JL. Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors. Clinical cancer research : an official journal of the American Association for Cancer Research 2016. PMID: 27683180


  18. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. The Lancet. Oncology 2016. PMID: 27569442


  19. Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Buono BD, Samuel D, Haas-Kogan DA, Chen J, Goldsby RE, Banerjee A, Lupo JM, Molinaro AM, Fullerton HJ, Mueller S. Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro-oncology 2016. PMID: 27540084


  20. Erika Roddy, Katherine Sear, Erin Felton, Benita Tamrazi, Karen Gauvain, Joseph Torkildson, Benedict Del Buono, David Samuel, Daphne Haas-Kogan, Josephine Chen, Robert Goldsby, Anu Banerjee, Janine Lupo, Annette Molinaro, Heather Fullerton, Sabine Mueller. RO-02CEREBRAL MICROBLEEDS ARE ASSOCIATED WITH WORSE EXECUTIVE FUNCTION IN PEDIATRIC BRAIN TUMOR SURVIVORS. Neuro-oncology 2016. PMID:



  21. Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatric blood & cancer 2016. PMID: 26891183



  22. Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer 2015. PMID: 26441212


  23. Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Gorlick R, Doski JJ, Womer RB, Janeway KA. Rapid Protocol Enrollment in Osteosarcoma: A Report From the Children's Oncology Group. Pediatric blood & cancer 2015. PMID: 26376351


  24. Fullerton HJ, Stratton K, Mueller S, Leisenring WW, Armstrong GT, Weathers RE, Stovall M, Sklar CA, Goldsby RE, Robison LL, Krull KR. Recurrent stroke in childhood cancer survivors. Neurology 2015. PMID: 26311747


  25. Madenci AL, Fisher S, Diller LR, Goldsby RE, Leisenring WM, Oeffinger KC, Robison LL, Sklar CA, Stovall M, Weathers RE, Armstrong GT, Yasui Y, Weldon CB. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015. PMID: 26261256


  26. Wong T, Goldsby RE, Wustrack R, Cash T, Isakoff MS, DuBois SG. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age. Pediatric blood & cancer 2015. PMID: 26173989


  27. Arin L Madenci, Stacey Fisher, Lisa Diller, Robert E. Goldsby, Wendy M. Leisenring, Kevin C. Oeffinger, Leslie L. Robison, Charles A. Sklar, Marilyn Stovall, Rita Weathers, Gregory T. Armstrong, Yutaka Yasui, Christopher Bertero Weldon. Intestinal obstruction in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology 2015. PMID:


  28. Lee JS, Padilla B, DuBois SG, Oates A, Boscardin J, Goldsby RE. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor. Pediatric blood & cancer 2015. PMID: 25809878


  29. Thampi S, Matthay KK, Boscardin WJ, Goldsby R, DuBois SG. Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma. Sarcoma 2014. PMID: 25294959


  30. Lee JS, DuBois SG, Boscardin WJ, Wustrack RL, Goldsby RE. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. Cancer 2014. PMID: 25116228


  31. Sheila Thampi, Katherine K. Matthay, W. John Boscardin, Robert Goldsby, Steven G. DuBois. Clinical features, outcomes, and prognostic factors in patients with extraskeletal osteosarcoma. Journal of Clinical Oncology 2014. PMID:


  32. Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, Frazier AL, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack B, Shead DA, Sundar H. Adolescent and young adult oncology, version 2.2014. Journal of the National Comprehensive Cancer Network : JNCCN 2014. PMID: 24453290


  33. Stieglitz E, Hsiang MS, Simko JP, Hirose S, Goldsby RE. Pulmonary coccidiomycosis masquerading as refractory metastatic Ewing sarcoma. Journal of pediatric hematology/oncology 2014. PMID: 23588326


  34. Sharib J, Horvai A, Gray Hazard FK, Daldrup-Link H, Goldsby R, Marina N, DuBois SG. Comparison of Latino and non-Latino patients with Ewing sarcoma. Pediatric blood & cancer 2013. PMID: 23970433



  35. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR. Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. International journal of radiation oncology, biology, physics 2013. PMID: 23680033



  36. Karski EE, Matthay KK, Neuhaus JM, Goldsby RE, Dubois SG. Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis. Cancer epidemiology 2012. PMID: 22959474


  37. Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack BJ, Sundar H, Shead DA. Adolescent and young adult oncology. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2012. PMID: 22956810


  38. Applebaum MA, Goldsby R, Neuhaus J, DuBois SG. Clinical features and outcomes in patients with secondary Ewing sarcoma. Pediatric blood & cancer 2012. PMID: 22847990


  39. Applebaum MA, Sambrano E, Lee S, Goldsby R, Matthay KK, DuBois SG. Evaluation of plasma annexin V levels in children and young adults with solid tumors. The International journal of biological markers 2012. PMID: 22610756


  40. Kan L, Kitterman JA, Procissi D, Chakkalakal S, Peng CY, McGuire TL, Goldsby RE, Pignolo RJ, Shore EM, Kaplan FS, Kessler JA. CNS demyelination in fibrodysplasia ossificans progressiva. Journal of neurology 2012. PMID: 22736080



  41. Sabine Mueller, Heather J Fullerton, Kayla Stratton, Wendy Leisenring, Rita E Weathers, Marilyn Stovall, Gregory T Armstrong, Robert E Goldsby, Roger J Packer, Leslie L Robison, Kevin R Krull. Abstract 8: Radiation and modifiable Stroke Risk Factors in adult Survivors of Pediatric Cancer: Results from the Childhood Cancer Survivor Study. Stroke 2012. PMID:



  42. Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG. Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatric blood & cancer 2011. PMID: 22180320


  43. Gawande RS, Khurana A, Messing S, Zhang D, Castañeda RT, Goldsby RE, Hawkins RA, Daldrup-Link HE. Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology 2011. PMID: 22157202


  44. DuBois SG, Goldsby R, Segal M, Woo J, Copren K, Kane JP, Pullinger CR, Matthay KK, Witte J, Lessnick SL, Robison LL, Bhatia S, Strong LC. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study. Pediatric blood & cancer 2011. PMID: 21793187


  45. Goldsby R, Chen Y, Raber S, Li L, Diefenbach K, Shnorhavorian M, Kadan-Lottick N, Kastrinos F, Yasui Y, Stovall M, Oeffinger K, Sklar C, Armstrong GT, Robison LL, Diller L. Survivors of childhood cancer have increased risk of gastrointestinal complications later in life. Gastroenterology 2011. PMID: 21315721


  46. DuBois SG, Stempak D, Wu B, Mokhtari RB, Nayar R, Janeway KA, Goldsby R, Grier HE, Baruchel S. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma. Pediatric blood & cancer 2011. PMID: 21319292


  47. Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011. PMID: 21692057



  48. Burk TF, Horvai AE, Gottschalk AR, Leong SP, Kashani-Sabet M, Goldsby RE, Law J, O'Donnell RJ. Patellar metastatic melanoma in a 13-year-old boy. American journal of orthopedics (Belle Mead, N.J.) 2010. PMID: 21720575


  49. Virayavanich W, Singh R, O'Donnell RJ, Horvai AE, Goldsby RE, Link TM. Osteoid osteoma of the femur in a 7-month-old infant treated with radiofrequency ablation. Skeletal radiology 2010. PMID: 20694724


  50. Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Osteosarcoma in children 5 years of age or younger at initial diagnosis. Pediatric blood & cancer 2010. PMID: 20582978


  51. Tina M. Albertson, Laura E. Hays, James M. Bugni, Masanori Ogawa, Piper M. Treuting, Robert E. Goldsby, Bradley D. Preston. Polymerase delta and epsilon proofreading cooperate with MMR to suppress lethal mutations and cancer in mice. The FASEB Journal 2010. PMID:


  52. Jha P, Frölich AM, McCarville B, Navarro OM, Babyn P, Goldsby R, Daldrup-Link H. Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging. Pediatric radiology 2010. PMID: 20180103


  53. Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2010. PMID: 20052725


  54. Denah Taggart, Robert Goldsby, Anuradha Banerjee. Late Effects of Treatment and Palliative Care. Pediatric CNS Tumors 2010. PMID:



  55. Albertson TM, Ogawa M, Bugni JM, Hays LE, Chen Y, Wang Y, Treuting PM, Heddle JA, Goldsby RE, Preston BD. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proceedings of the National Academy of Sciences of the United States of America 2009. PMID: 19805137



  56. Jabbari S, Andolino D, Weinberg V, Missett BT, Law J, Wara WM, O'Donnell RJ, Matthay KK, DuBois SG, Goldsby R, Haas-Kogan DA. Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. International journal of radiation oncology, biology, physics 2009. PMID: 19410386


  57. Goldsby R, Burke C, Nagarajan R, Zhou T, Chen Z, Marina N, Friedman D, Neglia J, Chuba P, Bhatia S. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Cancer 2008. PMID: 18823030


  58. Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. European journal of nuclear medicine and molecular imaging 2008. PMID: 18719909



  59. Lown EA, Goldsby R, Mertens AC, Greenfield T, Bond J, Whitton J, Korcha R, Robison LL, Zeltzer LK. Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. Addiction (Abingdon, England) 2008. PMID: 18554347


  60. Liles A, Blatt J, Morris D, Wardrop R, Sharma A, Sznewajs A, Goldsby R, Children's Oncology Group. Monitoring pulmonary complications in long-term childhood cancer survivors: guidelines for the primary care physician. Cleveland Clinic journal of medicine 2008. PMID: 18646589


  61. Daldrup-Link HE, Hawkins RA, Meier R, Goldsby RE, Artemov D. Receptor imaging of pediatric tumors: clinical practice and new developments. Pediatric radiology 2008. PMID: 18483730


  62. Kaplan FS, Le Merrer M, Glaser DL, Pignolo RJ, Goldsby RE, Kitterman JA, Groppe J, Shore EM. Fibrodysplasia ossificans progressiva. Best practice & research. Clinical rheumatology 2008. PMID: 18328989


  63. M Kleis, HE Daldrup-Link, KK Matthay, RE Goldsby, EJ Rummeny, T Schuster, RA Hawkins, BL Franc. PET/CT Staging und Restaging maligner Tumore bei Kindern und Jugendlichen. RöFo 2008. PMID:


  64. Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, Vietti TJ, Grier HE. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatric blood & cancer 2007. PMID: 17584910


  65. S. Jabbari, D. Andolino, V.K. Weinberg, J. Law, W.M. Wara, K.K. Matthay, R. Goldsby, R.J. O'Donnell, D.A. Haas-Kogan. Successful Treatment of Pediatric Desmoids Using Radiation as a Component of Multimodality Therapy. International Journal of Radiation Oncology • Biology • Physics 2007. PMID:


  66. Venkatesan RN, Treuting PM, Fuller ED, Goldsby RE, Norwood TH, Gooley TA, Ladiges WC, Preston BD, Loeb LA. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Molecular and cellular biology 2007. PMID: 17785453


  67. Nathan PC, Patel SK, Dilley K, Goldsby R, Harvey J, Jacobsen C, Kadan-Lottick N, McKinley K, Millham AK, Moore I, Okcu MF, Woodman CL, Brouwers P, Armstrong FD, Children's Oncology Group Long-term Follow-up Guidelines Task Force on Neurocognitive/Behavioral Com. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Archives of pediatrics & adolescent medicine 2007. PMID: 17679663





  68. Wagner LM, McAllister N, Goldsby RE, Rausen AR, McNall-Knapp RY, McCarville MB, Albritton K. Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma. Pediatric blood & cancer 2007. PMID: 16317751


  69. Crompton BD, Goldsby RE, Weinberg VK, Feren R, O'Donnell RJ, Ablin AR. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatric blood & cancer 2006. PMID: 16123980


  70. Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Annals of the New York Academy of Sciences 2006. PMID: 17102115



  71. Goldsby RE, Taggart DR, Ablin AR. Surviving childhood cancer: the impact on life. Paediatric drugs 2006. PMID: 16608369




  72. Kim GE, Beach B, Gastier-Foster JM, Murata-Collins JL, Rowland JM, O'Donnell RJ, Goldsby RE. Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia. Pediatric blood & cancer 2005. PMID: 15700259


  73. J. M. Maris, G. Yanik, J. Messina, L. Kersun, R. E. Goldsby, J. Huberty, J. Veatch, P. Brophy, S. C. Cheng, R. E. Hawkins, K. K. Matthay. A phase II study of
    131
    I-MIBG for refractory neuroblastoma.
    Journal of Clinical Oncology 2005. PMID:


  74. L. M. Wagner, N. McAllister, A. Rausen, B. McCarville, R. Goldsby, K. Albritton. Temozolomide and intravenous irinotecan for refractory Ewing’s sarcoma: A retrospective review. Journal of Clinical Oncology 2005. PMID:


  75. Iemsawatdikul K, Gooding CA, Twomey EL, Kim GE, Goldsby RE, Cohen I, O'Donnell RJ. Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma. Pediatric radiology 2005. PMID: 15756542


  76. Richard S. Lemons, Robert E. Goldsby. Chapter 162 Leukemias. Pediatrics 2005. PMID:


  77. Robert E. Goldsby, Richard S. Lemons. Chapter 163 Lymphomas. Pediatrics 2005. PMID:



  78. Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K, Stewart CF, Santana VM. Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2004. PMID: 14871959




  79. Longacre A, Sun T, Goldsby RE, Preston BD, Storb U. Ig gene somatic hypermutation in mice defective for DNA polymerase delta proofreading. International immunology 2003. PMID: 12663677


  80. Meeker ND, Goldsby R, Terrill KR, Delaney KS, Slayton WB. Dapsone therapy for children with immune thrombocytopenic purpura. Journal of pediatric hematology/oncology 2003. PMID: 12571474



  81. Holt D, Brown J, Terrill K, Goldsby R, Meyers RL, Heximer J, Nordfors B, Slayton WB. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 2003. PMID: 12509559



  82. Goldsby R, Pulsipher M, Adams R, Coffin C, Albritton K, Wagner L. Unexpected pleural effusions in 3 pediatric patients treated with STI-571. Journal of pediatric hematology/oncology 2002. PMID: 12439048


  83. Goldsby RE, Lawrence NA, Hays LE, Olmsted EA, Chen X, Singh M, Preston BD. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nature medicine 2001. PMID: 11385474